Medicus Pharma’s Roth Conference Participation Signals New Growth in Clinical Trials
Medicus Pharma, a clinical‑stage biotech investor, joins the Roth Conference to spotlight its FDA‑trial strategy and growth plans amid volatile Nasdaq trading.
2 minutes to read